v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue $ 50,959 $ 20,254
Cost of revenue 4,139 2,330
Gross profit 46,820 17,924
Operating expenses:    
Research and development expenses 15,597 19,871
Selling, general and administrative expenses 51,486 34,967
Operating loss (20,263) (36,914)
Financing on prepaid forward obligation (4,506) (4,583)
Interest expense on long-term debt (4,185) (4,068)
Interest and other income, net 608 2,114
Loss before income taxes (28,346) (43,451)
Income tax benefit (expense) 4,772 (392)
Net Loss (23,574) (43,843)
Statements of Comprehensive Loss    
Net loss (23,574) (43,843)
Other comprehensive loss    
Unrealized loss on investments (11) (42)
Comprehensive Loss $ (23,585) $ (43,885)
Net loss per ordinary share - basic and diluted (in dollars per share) $ (0.47) $ (0.92)
Weighted average number of shares outstanding used in computation of basic and diluted loss per ordinary share (in shares) 50,182,758 47,422,119